Surgical Site Infection Market is Forecasted to Reach $5.9 Billion by 2023: P&S Intelligence

NEW YORK, July 24, 2018 (GLOBE NEWSWIRE) — According to the market research report published by P&S Intelligence, global  is forecasted to reach $5.9 billion by 2023, the industry growth can be attributed to the development of technologically advanced products and growing geriatric population. Furthermore, increasing number of surgical procedures and rising incidence of SSIs are boosting the market growth.

Request to get the sample of this report @

Antibiotic prophylaxis products generated the largest revenue in the surgical site infection market in 2017. In most cases, patients’ sensitivity to certain drugs creates the need for specific antibiotics, which, in turn, adds to the treatment cost. Owing to this factor, antibiotic prophylaxis products continue to be in high demand in the market. However, the fastest growth in the market during the forecast period is expected from the antiseptic and disinfectant product category, with a CAGR of 7.4%.

Browse report overview with 113 tables and 68 figures spread through 177 pages and detailed TOC on “Surgical Site Infection (SSI) Market by Product (Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Wound Care Dressings, Surgical Drapes, Surgical Staff Clothing, Patient-Warming Products, Wound Care Supplementary Products, Clippers, Wound Irrigation Products), by Phase (Intraoperative Phase, Preoperative Phase, Postoperative Phase), by End User (Hospitals, Ambulatory Surgical Centers [ASCs], Clinics), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023” at:

Hospitals have been contributing the largest revenue to the surgical site infection market, owing to increase in the number of surgeries and a significant increase in the number of hospitals on a global level, which is further leading to the increased use of products that help prevent surgical site infections.

During the forecast period, the surgical site infection market is expected to witness the fastest growth in APAC, at a CAGR of 7.7%. The APAC surgical site infection market is also expected to reach $1,492.8 million by 2023. The market growth in APAC is mainly driven by growing geriatric population, rising incidence of SSIs, increasing adoption of technologically advanced products, and improving healthcare infrastructure.

According to the UN publication World Population Ageing 2017, in Asia, the number of people aged 60 years or above is estimated to increase from 549 million in 2017 to nearly 1.3 billion in 2050. Also, there is a high adoption rate of technologically advanced products in Japan. Besides, the country is witnessing an increase in its geriatric population. These factors are expected to continue driving the growth of the surgical site infection market market in Japan.

According to Japan Nosocomial Infections Surveillance (JANIS), a national surveillance program organized by Japan’s Ministry of Health, Labour and Welfare (MHLW) in 2017, there were 117,209 cases of methicillin-resistant Staphylococcus aureus (MRSA) infection in 2012, which increased to 177,768 in 2016. Thus, increase in surgical site infections in Japan is boosting the demand for products that help fight these infections.

Make Enquiry Before Placing the Order @
In order to increase their market share, key players of the surgical site infection industry are entering into partnerships. For instance, in January 2018, Mölnlycke Health Care AB entered into a partnership with Tissue Analytics, a developer of digital wound-imaging platforms. With this partnership, both the companies intend to jointly develop and commercialize innovative digital solutions (such as comprehensive clinical decision support tools) for wound care professionals.

Some of the other key players operating in the surgical site infection market are 3M Company, STERIS plc, Stryker Corporation, Medtronic plc, Prescient Surgical Inc., Covalon Technologies Ltd., Surgical Site Infection Prevention LLC, HARTMANN GROUP, B. Braun Melsungen AG, and Becton, Dickinson and Company.

More Reports by P&S Intelligence

Protein Extracts from Single Cell Protein Sources Market –

Sleep Apnea Devices Market –

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

:
P&S Intelligence

Toll-free: + (USA/Canada)

International: +

Web:

Connect with us:  |  |  |